Track Heska (Restricted Voting)'s total revenue ($250M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2023
Trailing 12 months ending Mar 2023
Heska (Restricted Voting) posts a total revenue of $250M as of March 2023. That compares with $260M in the prior-year period — down 1.2% year over year. That is below the Healthcare sector average of $110B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Heska (Restricted Voting)'s total revenue was $260M. The latest reading is $250M — a 1.2% year-over-year decrease (period ending March 2023). Use the history and growth charts on this page for a longer lookback.
For Healthcare stocks, a total revenue near $110B is typical. Heska (Restricted Voting)'s $250M is lower that level. That is roughly 99.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Total Revenue is one piece of Heska (Restricted Voting)'s financial statement story. At $250M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for HSKA's total revenue usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $110B), and (3) consistency with growth and profitability. This page covers the first two; Heska (Restricted Voting)'s other metric pages and overview cover the third.